Literature DB >> 8620161

Methadone maintenance reduces injecting in prison.

K Dolan, W Hall, A Wodak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8620161      PMCID： PMC2350651          DOI： 10.1136/bmj.312.7039.1162b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Drugs, HIV, and prisons.

Authors:  M Farrell; J Strang
Journal:  BMJ       Date:  1991-06-22

Review 2.  AIDS behind bars: preventing HIV spread among incarcerated drug injectors.

Authors:  K Dolan; A Wodak; R Penny
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

3.  Outbreak of HIV infection in a Scottish prison.

Authors:  A Taylor; D Goldberg; J Emslie; J Wrench; L Gruer; S Cameron; J Black; B Davis; J McGregor; E Follett
Journal:  BMJ       Date:  1995-02-04
  3 in total
  16 in total

1.  Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.

Authors:  R Douglas Bruce; Rebecca A Schleifer
Journal:  Int J Drug Policy       Date:  2008-01-15

Review 2.  A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors:  R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal:  Expert Rev Clin Pharmacol       Date:  2013-05       Impact factor: 5.045

3.  Methadone treatment is widely accepted in prisons in New South Wales.

Authors:  A Byrne; K Dolan
Journal:  BMJ       Date:  1998-06-06

4.  Drug use in prison. Methadone maintenance in prison needs to be evaluated.

Authors:  S M Gore; S Seaman
Journal:  BMJ       Date:  1996-08-17

5.  A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison.

Authors:  Michael S Gordon; Timothy W Kinlock; Kathryn A Couvillion; Robert P Schwartz; Kevin O'Grady
Journal:  J Offender Rehabil       Date:  2012-05-01

6.  Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.

Authors:  Elana S Rosenthal; Rachel Silk; Poonam Mathur; Chloe Gross; Rahwa Eyasu; Laura Nussdorf; Kristi Hill; Christopher Brokus; Aaron D'Amore; Nadeera Sidique; Phyllis Bijole; Miriam Jones; Randy Kier; Dana McCullough; David Sternberg; Kristen Stafford; Junfeng Sun; Henry Masur; Shyamasundaran Kottilil; Sarah Kattakuzhy
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

7.  Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.

Authors:  Bohdan Nosyk; Daphne P Guh; Nicholas J Bansback; Eugenia Oviedo-Joekes; Suzanne Brissette; David C Marsh; Evan Meikleham; Martin T Schechter; Aslam H Anis
Journal:  CMAJ       Date:  2012-03-12       Impact factor: 8.262

8.  Incidence and risk for acute hepatitis C infection during imprisonment in Australia.

Authors:  Kate Dolan; Suzy Teutsch; Nicolas Scheuer; Michael Levy; William Rawlinson; John Kaldor; Andrew Lloyd; Paul Haber
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

9.  A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.

Authors:  Michael S Gordon; Timothy W Kinlock; Robert P Schwartz; Kevin E O'Grady
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

10.  Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Authors:  R Douglas Bruce
Journal:  Int J Drug Policy       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.